Medicine Information Article:

Vioxx and Bextra Lawsuits Could Tie Up Courts for Years

In September, 2004, pharmaceutical giant Merck voluntarily withdrew its painkilling medication Vioxx from the market. Studies show that Vioxx increases the risk of heart attack and stroke among patients who have used the drug for longer than 18 months. Vioxx, a drug from a family of non-steroidal anti-inflammatory drugs known as COX-2 inhibitors, is one of only a few drugs specifically designed to minimize inflammation while avoiding the stomach disorders long associated with other anti-inflammatory medications. Since its introduction in 1999, Vioxx has been a huge success, and sales of the drug worldwide topped $2.5 billion in 2003. That is certainly a great deal of money, but it pales when compared to the amount that Merck stands to lose through product liability lawsuits, which will soon come to court. As of this writing, several thousand lawsuits have been filed nationally, but attorneys estimate that the total number of lawsuits filed could reach a staggering 100,000.

One hundred thousand lawsuits is certainly a formidable number, but that figure could represent only half of the number of lawsuits related to COX-2 inhibitors. Earlier this year, Pfizer voluntarily withdrew its similar medication Bextra from the market, as studies linked the use of Bextra to increased heart attack risk and to a rare skin disorder known as Stevens-Johnson Syndrome. Bextra, another drug in the family of COX-2 inhibitors, works very similarly to Vioxx, and many patients who formerly took Vioxx switched to Bextra after the former was removed from the market last fall. Given that sales of Bextra rose to near Vioxx levels before it was removed from the market, it seems likely that the number of lawsuits filed by patients who claim to have been harmed by their use of Bextra could eventually equal the number of Vioxx lawsuits.

Unless the courts consolidate them into just a few class-action suits, the 200,000 potential lawsuits stemming from problems with Bextra and Vioxx could cripple our courts for the next decade. Patients who believe that they may have been harmed through the use of either Bextra or Vioxx would be well advised to contact an attorney who specializes in pharmaceutical lawsuits as soon as possible. The wait for a resolution in court, particularly for Vioxx lawsuits, could be a very long one. Those who file quickly may get the fastest results.

©Copyright 2005 by Retro Marketing.

Charles Essmeier is the owner of Retro Marketing, a firm devoted to informational Websites, including Bextra-Info.net, a site devoted to the withdrawn drug Bextra and StructuredSettlementHelp.com, a site devoted to structured settlements.

Did you know that you most likely live within a short distance of cheaper prescription medicine than you are now paying? If you are having to choose between filling your prescription or buying food for you and your family, you may want to read on. This article will not only explain how you can save thousands of dollars in prescription medicine but also where you can get it for a lot less.

Is oral chelation therapy more effective than IV chelation therapy? It depends on the patient and his or her needs and desired outcome. When oral chelation therapy is done correctly with the correct dose of cysteine, the effects are often high quality and quite useful when treating heavy metal toxicity or treating hardened arteries.

Fentanyl isn't exactly a household name. However, it's considered in the same league as other recreational drugs, such as heroin an ecstasy, albeit for the fact that it's much more dangerous. As a matter of fact, this drug has a potency that is eighty times that of heroin. What makes it slightly redeemable in the eyes of the scientific community is its medicinal properties.

With winter fast arriving, what steps will you take to prevent your workplace being crippled by the Flu? Discover the benefits of in-house flu vaccinations and how you can prevent your business becoming a part of this costly virus.

More than 15,000 people in the United States are currently waiting for liver transplants according to UNOS, the United Network for Organ Sharing. However, only 4500 - 5000 cadaver donor livers become available each year, and more than 1700 people in the US die each year awaiting a donor liver. Since there is no dialysis for liver failure as there is for kidney failure, patients must either get a transplant or die.